Preanalytical assay: enrichment of tumor derived genomic DNA from human biofluids
Human plasma, serum, urine.
0.5 – 2 ml of human biofluid.
Number of reactions:
Enrichment of tumor derived genomic DNA.
SeleCTEV™ DNA Enrichment Kit allows the selective purification of circulating free DNA (cfDNA) and tumor-derived extracellular vesicles (EVs) DNA from plasma. The isolation is based on Exosomics’ proprietary peptide affinity method.